Conceptrichtlijn colorectaal carcinoom 2013 - Oncoline

834383448345834683478348834983508351835283538354835583568357835883598360836183628363836483658366836783688369837083718372837383748375837683778378837983808381838283838384838583868387838883898390839183928393Sanoff HK, Carpenter WR, Stürmer T, Goldberg RM, Martin CF, Fine JP, et al. Effect of adjuvant chemotherapyon survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol. 2012 Jul20;30(21):2624-34.Sargent DJ, Patiyil S, Yothers G, Haller DG, Gray R, Benedetti J, et al; ACCENT Group. End points for coloncancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patientsenrolled onto 18 randomized trials from the ACCENT Group. J Clin Oncol. 2007 Oct 10;25(29):4569-74. Epub2007 Sep 17.Sargent D, Marsoni S, Monges G, et al.(2010) Defective mismatch repair as a predictive marker for lack ofefficacy of FU-based adjuvant therapy in colon cancer. J Clin Oncol 28:3219–27.Sargent D, Shi Q, Yothers G, Van Cutsem E, Cassidy J, Saltz L, et al; Adjuvant Colon Cancer End-points(ACCENT) Group. Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvantcolon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients fromMOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803. Eur J Cancer. 2011 May;47(7):990-6.Sastre J, Marcuello E, Masutti B, Navarro M, Gil S, Anton A, et al.Cooperative Group for the Treatment ofDigestive Tumors. Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-linechemotherapy for elderly patients with metastatic colorectal cancer: a Spanish Cooperative Group for theTreatment of Digestive Tumors study. J Clin Oncol. 2005 May 20;23(15):3545-51Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R et al. Preoperative versus postoperativechemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40.Schefter TE, Kavanagh BD, Timmerman RD, et al. A phase I trial of stereotactic body radiation therapy (SBRT)for liver metastases. Int J Radiat Oncol Biol Phys 2005 Aug 1;62(5):1371-8.Schell SR, Zlotecki RA, Mendenhall WM, Marsh RW, Vauthey JN, Copeland EM, 3rd. Transanal excision oflocally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy. Journal of the AmericanCollege of Surgeons. 2002;194(5):584-90; discussion 90-1.Schiffman SC, Bower M, Brown RE, Martin RC, McMasters KM, Scoggins CR. Hepatectomy is superior tothermal ablation for patients with a solitary colorectal liver metastasis. J Gastrointest Surg. 2010Dec;14(12):1881-6.Schild SE, Gunderson LL, Haddock MG, Wong WW, Nelson H. The treatment of locally advanced colon cancer.Int.J.Radiat.Oncol.Biol.Phys. 1997;37(1):51-8.Schmidt J, Strotzer M, Fraunhofer S, Boedeker H, Zirngibl H. Intraoperative ultrasonography versus helicalcomputed tomography and computed tomography with arterioportography in diagnosing colorectal livermetastases: lesion-by-lesion analysis. World J Surg 2000;24:43-47.Schmoll HJ, Cunningham D, Sobrero A, et al. Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study(HORIZON III). J Clin Oncol 2012;30:3588-95.Schneider PD. Preoperative assessment of liver function. Surg Clin North Am 2004;84:355-373.Schoemaker D, Black R, Giles L. Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence5-year survival of colorectal cancer patients. Gastroenterology 1998;114:7-14.Richtlijn Colorectaal carcinoom en Colorectale levermetastasen 2013 - CONCEPT 191